Kenvue Met RFK Jr. in Bid to Keep Tylenol Off Autism List (1)

Sept. 12, 2025, 4:36 PM UTC

Tylenol-maker Kenvue Inc. spoke with Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller off a list of autism-causing treatments.

The conversation, disclosed by the company, follows reports that Kennedy plans to link pregnant women’s use of acetaminophen, which is the active ingredient in Tylenol, to autism in their children. That publication is expected later this month.

“We engaged in a scientific exchange with the secretary and members of his staff as it relates to the safety of our products,” Kenvue said in an emailed statement. “We continue to believe that taking acetaminophen does ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.